Cite
HARVARD Citation
Ahn, H. et al. (n.d.). Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma. European journal of cancer. pp. S105-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ahn, H. et al. (n.d.). Cancer-associated fibroblast-derived SPP1 is a potential target for overcoming sorafenib and lenvatinib resistance in hepatocellular carcinoma. European journal of cancer. pp. S105-. [Online].